Mesa Laboratories Analyst Price Targets

Wall Street analyst price targets and consensus rating for Mesa Laboratories (MLAB).

Price Target Range — 9 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingEqual-Weight# Analysts1Avg. Consensus PT$121Upside to Avg. PT-3.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 14, 2026	Wells Fargo	Evan Stampler	PT Raise	Equal-Weight	$94→$110
Feb 4, 2026	Wells Fargo	Brandon Couillard	PT Raise	Equal-Weight	$83→$94
Dec 15, 2025	Wells Fargo	Brandon Couillard	PT Raise	Equal-Weight	$75→$83
Aug 8, 2025	Wells Fargo	Brandon Couillard	Upgrade	Underweight→Equal-Weight	$100→$67
May 30, 2025	Wells Fargo	Brandon Couillard	PT Cut	Underweight	$120→$100
Oct 1, 2024	Evercore ISI Group	Vijay Kumar	PT Raise	Outperform	$120→$160
Aug 27, 2024	Wells Fargo	Brandon Couillard	Initiate	Underweight	$120
Aug 6, 2024	Evercore ISI Group	Vijay Kumar	PT Raise	Outperform	$106→$120
Jul 2, 2024	Evercore ISI Group	Vijay Kumar	PT Cut	Outperform	$120→$106
Apr 4, 2024	Evercore ISI Group	Vijay Kumar	PT Raise	Outperform	$124→$130
Jan 4, 2024	Evercore ISI Group	Vijay Kumar	Upgrade	In-Line→Outperform	$100→$125

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $110

Wells Fargo analyst Evan Stampler maintains Mesa Laboratories (NASDAQ:MLAB) with a Equal-Weight and raises the price target from $94 to $110.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $94

Wells Fargo analyst Brandon Couillard maintains Mesa Laboratories (NASDAQ:MLAB) with a Equal-Weight and raises the price target from $83 to $94.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $83

Wells Fargo analyst Brandon Couillard maintains Mesa Laboratories (NASDAQ:MLAB) with a Equal-Weight and raises the price target from $75 to $83.

Benzinga Newsdesk

PRO
Wells Fargo Upgrades Mesa Laboratories to Equal-Weight, Lowers Price Target to $67

Wells Fargo analyst Brandon Couillard upgrades Mesa Laboratories (NASDAQ:MLAB) from Underweight to Equal-Weight and lowers the price target from $100 to $67.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Underweight on Mesa Laboratories, Lowers Price Target to $100

Wells Fargo analyst Brandon Couillard maintains Mesa Laboratories (NASDAQ:MLAB) with a Underweight and lowers the price target from $120 to $100.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Mesa Laboratories, Raises Price Target to $160

Evercore ISI Group analyst Vijay Kumar maintains Mesa Laboratories (NASDAQ:MLAB) with a Outperform and raises the price target from $120 to $160.

Benzinga Newsdesk

Mesa Laboratories Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Mesa Laboratories Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $110

PRO
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $94

PRO
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $83

PRO
Wells Fargo Upgrades Mesa Laboratories to Equal-Weight, Lowers Price Target to $67

PRO
Wells Fargo Maintains Underweight on Mesa Laboratories, Lowers Price Target to $100

PRO
Evercore ISI Group Maintains Outperform on Mesa Laboratories, Raises Price Target to $160

People Also Watch

People Also Watch

Mesa Laboratories Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Mesa Laboratories Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROWells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $110

PROWells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $94

PROWells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $83

PROWells Fargo Upgrades Mesa Laboratories to Equal-Weight, Lowers Price Target to $67

PROWells Fargo Maintains Underweight on Mesa Laboratories, Lowers Price Target to $100

PROEvercore ISI Group Maintains Outperform on Mesa Laboratories, Raises Price Target to $160

People Also Watch

People Also Watch

PRO
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $110

PRO
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $94

PRO
Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $83

PRO
Wells Fargo Upgrades Mesa Laboratories to Equal-Weight, Lowers Price Target to $67

PRO
Wells Fargo Maintains Underweight on Mesa Laboratories, Lowers Price Target to $100

PRO
Evercore ISI Group Maintains Outperform on Mesa Laboratories, Raises Price Target to $160